Abbott Laboratories

Ahead of PM Narendra Modi's visit, US lawmakers ask India to rethink price cap on stents

The Modi government has in recent years capped prices of hundreds of life-saving drugs to make them more affordable.

Govt panel proposes to regulate prices of patented drugs

A panel formed under the ministry of chemicals and fertilizers has recommended setting up a committee to negotiate with drugmakers to fix prices of costly drugs used to treat deadly diseases such as cancer, HIV and hepatitis.

Abbott, Biocon to join hands, develop nutrition products for India

Abbott Laboratories has partnered Indian biotechnology company Biocon Ltd to develop nutrition products for India, as the US drugmaker steps up its push to tap a potentially big market.

The 11% solution: Why Piramal has taken a bigger bite of Vodafone

Ajay Piramal, who made a healthy exit from Abbott and reaped loads of cash, has now bought a bigger share of Vodafone. Here's his gameplan